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ABSTRACT
Background: For older groups, being overweight [body mass index
(BMI; in kg/m2): 25 to,30] is reportedly associated with a lower or
similar risk of mortality than being normal weight (BMI: 18.5 to
,25). However, this “risk paradox” is partly explained by smoking
and disease-associated weight loss. This paradox may also arise
from BMI failing to measure fat redistribution to a centralized
position in later life.
Objective: This study aimed to estimate associations between com-
bined measurements of BMI and waist-to-hip ratio (WHR) with
mortality and incident coronary artery disease (CAD).
Design: This study followed 130,473 UK Biobank participants aged
60–69 y (baseline 2006–2010) for #8.3 y (n = 2974 deaths). Current
smokers and individuals with recent or disease-associated (e.g., from
dementia, heart failure, or cancer) weight loss were excluded, yielding
a “healthier agers” group. Survival models were adjusted for age, sex,
alcohol intake, smoking history, and educational attainment. Population
and sex-specific lower and higher WHR tertiles were,0.91 and$0.96
for men and ,0.79 and $0.85 for women, respectively.
Results: Ignoring WHR, the risk of mortality for overweight sub-
jects was similar to that for normal-weight subjects (HR: 1.09; 95% CI:
0.99, 1.19; P = 0.066). However, among normal-weight subjects,
mortality increased for those with a higher WHR (HR: 1.33; 95% CI:
1.08, 1.65) compared with a lower WHR. Being overweight with
a higher WHR was associated with substantial excess mortality
(HR: 1.41; 95% CI: 1.25, 1.61) and greatly increased CAD in-
cidence (sub-HR: 1.64; 95% CI: 1.39, 1.93) compared with being
normal weight with a lower WHR. There was no interaction be-
tween physical activity and BMI plus WHR groups with respect to
mortality.
Conclusions: For healthier agers (i.e., nonsmokers without
disease-associated weight loss), having central adiposity and a BMI
corresponding to normal weight or overweight is associated with sub-
stantial excess mortality. The claimed BMI-defined overweight risk
paradox may result in part from failing to account for central adipos-
ity, rather than reflecting a protective physiologic effect of higher
body-fat content in later life. Am J Clin Nutr 2017;106:130–5.
Keywords: overweight, adiposity, waist-hip ratio, mortality, body
mass index, coronary artery disease, UK Biobank, aging, older
persons
INTRODUCTION
The prevalence of BMI-defined overweight and obesity [in kg/m2;
25 to ,30 and $30, respectively] in adults has increased dramat-
ically since 1980, with an estimated 2.1 billion adults affected
globally in 2013 (1). Younger and middle-aged adults classified as
overweight or class I obese (BMI: 30 to ,35) have substantially
increased risks for mortality relative to normal-weight individuals
(BMI: 18.5 to ,25) (2, 3). However, paradoxical associations for
persons within the overweight and class I obese BMI categories
have been reported for those aged$65 y; several meta-analyses and
cohort studies show that persons with BMI-defined overweight have
mortality risks that are reduced (4, 5) or similar (6–8) to individuals
with a normal BMI. Some researchers claim that this paradox may
reflect a protective physiologic effect of a slightly higher BMI (9)
and challenge the idea that conventional BMI thresholds should be
used in older persons (6, 9–11), arguing that this paradox justifies a
revision of the current scientific consensus on the health dangers of
being overweight. Others have claimed that public health re-
searchers “would rather not talk about” studies that show that being
overweight does not always shorten life (12).
Our recent analysis of 955,000 population-representative
primary care patients showed that paradoxical overweight and
moderate-obesity mortality risks for adults aged 60–84 y were
partly explained by confounding from inclusion of smokers and
subjects with disease-associated weight loss (13). We found that
in “healthier agers” (nonsmokers without disease-associated
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weight loss), class I obesity was associated with excess mortality
and coronary artery disease (CAD) (13); that is, the obesity risk
paradox reversed to being nonparadoxical. A further possible bias
in the paradoxical associations for BMI-defined overweight (and
class I obese) persons may be that BMI does not distinguish be-
tween fat and fat-free mass (6, 14). This limitation of BMI may be
accentuated in older age groups; after 60 y, fat-free mass decreases
and fat mass is redistributed (15, 16) to a more central deposition.
Weight loss attributable to the depletion of skeletal mass and height
loss during aging may reduce the accuracy of BMI in later life (14).
By age 70 y, BMI values are reported to be inflated by 0.7 for men
and 1.6 for women (17).
Here we estimated associations between combined BMI and
central adiposity measurements with mortality and incident CAD
in a large older cohort. The UKBiobank offers an ideal opportunity
to estimate these associations in a large sample of “healthier agers”
(nonsmokers without disease-associated weight loss) in their
seventh decade, in whom the distribution of fat stores to a more
central distribution is measured. Waist-to-hip ratio (WHR) is a
well-recognized measure of central adiposity (14), includes some
adjustment for body shape, and has a relatively weak correlation
with BMI (compared with waist circumference alone, which is
more strongly correlated with BMI) (7, 17).
METHODS
Between 2006 and 2010, the UK Biobank recruited .500,000
volunteers across England, Wales, and Scotland; the majority of
respondents were aged 40–69 y (range: 37–73 y). At baseline,
participants provided self-reports for demographic, socioeco-
nomic, and lifestyle factors. A range of physical measurements,
including anthropometrics and blood samples, were also taken at
participants’ baseline visit (18, 19). Participants provided informed
consent to have their records linked to cancer registrations, hos-
pital admissions, and death registries. The overall response rate was
5.5%, and further cohort details were published previously (18).
For this analysis, we included individuals aged 60–69 y at
recruitment. The UK Biobank aimed to recruit participants aged
40–69 y (2247 participants were aged .69 y by the time they
were interviewed). We selected only those aged 60–69 y because
the obesity paradox has been reported predominantly for this age
group and older groups, most female participants were post-
menopausal, and fat-mass redistribution to a more central de-
position is generally well established in this age group. We
excluded participants who were missing BMI (n = 1299), waist
(n = 44), or hip (n = 20) measurements. Participants with a BMI
,18.5 or $35 (n = 14,926) were excluded, because the paradox
has predominately been reported for those with BMI values within
the overweight (25 to ,30) and class I obese (30 to ,35) ranges.
Participants with missing responses to questions on alcohol
intake, educational attainment, or smoking history were excluded
(n = 5019). To account for subjects with conditions associated
with weight loss or altered body distribution, we excluded cur-
rent smokers and patients who had a previous diagnosis of
cancer, heart failure, or dementia (n = 38,991), similar to pre-
vious reports (13). The chronic condition exclusions were based
on our previous analysis (13), which empirically tested the as-
sociations of 15 major diagnoses with measured weight loss in a
large sample (n = 955,000) of primary care patients: cancer,
heart failure, and dementia conferred the highest ORs ($1.5) for
measured weight loss. The resulting group consists of “healthier
agers” for whom population-level obesity prevention may be
relevant. Diagnoses at or before baseline were derived from
participants’ self-reports, cancer registries, and hospital admis-
sions (inpatients). We excluded participants whose death dates
were not reported (n = 1). We excluded the first 2 y of follow-up
(n = 677) to reduce the effects of reverse causation, whereby
underlying diseases are associated with a lower BMI and an
increased risk of death. Because previous weight loss is shown
to be associated with adverse outcomes, we excluded partici-
pants who reported at baseline having lost weight compared
with 1 y previously, did not know, or preferred not to answer
(n = 23,662). The available question on weight loss did not ask
about the degree of weight change or whether this weight
change was intentional or unintentional. Therefore, our exclu-
sion covered more substantial weight losses as well as minor
losses. The remaining sample for analysis thus included 130,473
participants (62,418 men and 68,055 women) (see the flowchart
in Supplemental Figure 1).
Exposures
Height, weight, and waist and hip circumferences were mea-
sured at the baseline examination after participants removed their
shoes and heavy outer clothing. The natural indent was measured
once for the waist circumference (the umbilicus was used if the
natural indent could not be observed). The hip circumference was
recorded once at the widest part of the hips (20). BMI and WHR
were derived from the baseline measurements. We used the WHO
BMI Classification as follows: normal weight, 18.5 to ,25.0;
overweight, 25 to ,30; and class I obesity, 30 to ,35 (21). We
categorized WHR by population and sex-specific tertiles as fol-
lows: lower WHR, ,0.91 for men and ,0.79 for women; in-
termediate WHR, 0.91 to ,0.96 for men and 0.79 to ,0.85 for
women; and higher WHR, $0.96 for men and $0.85 for women.
We also used the proposed WHO binary WHR abdominal obesity
cutoff points of .0.85 for women and .0.90 for men (22).
Covariates
Alcohol intake was defined based on frequency (daily or almost
daily, 3–4 times/wk, 1–2 times/wk, 1–3 times/mo, occasionally, and
never). Participants were categorized as never or former smokers.
The highest level of educational achievement was defined as
follows: none; certificate of secondary education; general certificate
of secondary education or ordinary level taken at age 15–16 y;
advance level, national vocational qualification, higher national
diploma, or higher national certificate further education after age
16 y; professional qualification; and college or university degree.
Ethnicity was categorized as white, mixed, Asian, black,
Chinese, and other. The mixed category combined the responses
of the UK Biobank ethnicity questions of “mixed,” “white and
black Caribbean,” “white and black African,” “white and
Asian,” and “any other mixed background.”
Participants were categorized as having low, moderate, or high
physical activity. This was determined from participants’ re-
sponses to frequency and duration of walking, moderate activity,
and vigorous activity using the validated International Physical
Activity Questionnaire. Total metabolic equivalent minutes of
exercise per week were then derived (23).
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Outcomes
Death certificate data were available up to 15 August 2015. These
data were collected by the Health and Social Care Information
Centre for English and Welsh participants and the Information
Services Department for Scottish participants. Data on incident
CAD (International Classification of Diseases, 10th revision, codes
I20–I25) were available up to 27 February 2015 from Hospital
Episode Statistics (England), the Scottish Morbidity Record
(Scotland), and the Patient Episode Database for Wales (Wales).
Statistical analysis
We used Pearson correlation analysis to evaluate the correla-
tions between anthropometric measurements. We used Cox pro-
portional hazards models for categorical mortality analyses (BMI
categories, WHR tertiles, and the joint associations of BMI and
WHR). Follow-up time for mortality risks was computed from the
assessment date until the date of death, or until 15 August 2015 (for
survivors). We used Schoenfeld residuals to test the proportional
hazards assumption. Competing risks models (accounting for
mortality) were used to estimate the association between an-
thropometric measurements and incident CAD. The follow-up
time for incident CAD risks was computed from the assessment
date until the date of incident CAD, date of death, or 27 February
2015. Multivariate models were adjusted for age, sex, alcohol
intake, smoking history (never or former smoker), and educational
attainment. These covariates were chosen because they are in line
with previous reports and are similar to our previous analysis (13).
We did not adjust for covariates along the casual pathway
(i.e., cholesterol and hypertension). Significancewas determined at
P, 0.05. The Akaike information criterion was obtained for each
model, with lower values generally indicating improved model
fits. Interactions of BMI and WHR tertiles with physical activity,
age (groups aged 60–64 y and 65–69 y), smoking history, and sex
were also evaluated. Analyses were carried out using Stata sta-
tistical software (version 14.0; StataCorp LP).
RESULTS
Baseline characteristics
Table 1 presents the baseline characteristics of the study
population (n = 130,473). The mean 6 SD BMI was 26.96 3.4;
48.9% and 19.5% of participants were classified as overweight
and class I obese, respectively. The mean WHR was 0.946 0.06
for men and 0.82 6 0.07 for women. The correlation between
BMI and WHR was 0.58 for men and 0.44 for women. Sex-
specific WHR tertiles were defined and derived from the overall
study population as follows: lower WHR, ,0.91 for men and
,0.79 for women; intermediate WHR, 0.91 to ,0.96 for men
and 0.79 to ,0.85 for women; and higher WHR, $0.96 for men
and $0.85 for women. The percentages of participants with
lower and higher WHRs were as follows: normal BMI, 57.7%
and 12.8%; overweight BMI, 27.1% and 35.2%; and class I
obesity, 9.6% and 62.0%, respectively (Supplemental Table 1).
Mortality
Over a maximum follow-up of 8.3 y, 2974 adults died (mean
follow-up: 6.5 6 0.9 y). In survival models adjusted for age,
sex, smoking history (never or former smoker), alcohol intake,
and educational attainment, individuals categorized as over-
weight (BMI: 25 to ,30) were not at a significantly increased
risk of mortality (HR: 1.09; 95% CI: 0.99, 1.19; P = 0.066)
relative to those categorized as normal weight (BMI: 18.5 to
,25). Individuals with class I obesity (BMI: 30 to ,35) had a
substantially increased mortality risk (HR: 1.27; 95% CI:
1.14, 1.41) compared with normal-weight individuals. Com-
pared with the lowest WHR tertile, the intermediate and
highest tertiles were associated with a 12% (HR: 1.12; 95% CI:
1.01, 1.23) and 36% (HR: 1.36; 95% CI: 1.24, 1.49) increased
risk of mortality, respectively. These associations with WHR
tertiles were attenuated after adjustment for BMI category,
with HRs of 1.10 (95% CI: 1.00, 1.21) and 1.32 (95% CI:
1.19, 1.46) for the intermediate and higher WHR tertiles,
respectively.
Combined associations of fat distribution and BMI
Model fits were improved when both BMI and WHR were
included compared with a model with BMI only. Figure 1A
shows the joint association between BMI category and WHR
tertiles (Supplemental Table 2). Among normal-weight sub-
jects, those with a higher WHR had increased mortality
TABLE 1
Baseline characteristics of UK Biobank participants aged 60–69 y
(n = 130,473)1
Variable Value
Age, y 64.1 6 2.8
Sex, F 68,055 (52.2)
BMI, kg/m2 26.9 6 3.4
Normal weight, 18.5 to ,25.0 41,369 (31.7)
Overweight, 25.0 to ,30.0 63,731 (48.9)
Class I obesity, 30.0 to ,35.0 25,373 (19.5)
Waist-to-hip ratio
Women 0.82 6 0.07
Men 0.94 6 0.06
Alcohol intake frequency
Never 9845 (7.6)
Special occasions only 13,973 (10.7)
1–3 times/mo 12,393 (9.5)
1–2 times/wk 31,348 (24.0)
3–4 times/wk 30,818 (23.6)
Daily or almost daily 32,096 (24.6)
Smoking history
Never smoker 72,419 (55.5)






Professional qualification 20,862 (16.0)
College or university degree 36,156 (27.7)
Diagnosed disease at baseline
Coronary artery disease 10,115 (7.8)
Type 2 diabetes 6781 (5.2)
Follow-up, y 6.5 6 0.9
1Values are means 6 SDs or n (%). A-levels/NVQ/HND/HNC, ad-
vance level/national vocational qualification/higher national diploma/higher
national certificate further education after age 16 y; CSE, certificate of
secondary education; GCSE/O-levels, general certificate of secondary edu-
cation/ordinary level taken at age 15–16 y.
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(HR: 1.33; 95% CI: 1.08, 1.65) compared with those with a
lower WHR. In addition, there was an increased risk of 22% and
42% for participants in the overweight (HR: 1.22; 95% CI: 1.09,
1.36) and class I obese (HR: 1.42; 95% CI: 1.25, 1.61) cate-
gories overall, respectively, compared with normal-weight
adults with a lower WHR. Overweight participants with a
higher WHR had a 41% increased risk (HR: 1.41; 95% CI: 1.25,
1.61) and class I obese participants with a higher WHR had a
51% increased risk (HR: 1.51; 95% CI: 1.32, 1.73) relative to
the group with a normal BMI and lower WHR.
CAD
At baseline, there were 10,115 prevalent cases of CAD and
these were excluded from the competing risk analysis for incident
CAD, yielding 120,358 participants in the competing risk
analysis of CAD (incident cases n = 1878). Figure 1B shows the
joint association between BMI category and WHR tertiles
(Supplemental Table 2). Overweight participants with a higher
WHR had a 64% increased risk for CAD (sub-HR: 1.64; 95%
CI: 1.39, 1.93) relative to normal-weight participants with a
lower WHR. There was also an increased risk for incident CAD
for overweight participants with a lower or intermediate WHR.
Within the group with class I obesity, there was an increased risk
for incident CAD for all WHR tertiles relative to the group
with a normal BMI and lower WHR tertile.
Sensitivity analyses
We repeated our main analysis (of the joint association between
BMI and WHR tertiles) with age as the underlying time scale, but
our results were not substantially changed (Supplemental Table
3). We performed an analysis using the proposed WHO WHR
abdominal obesity cutoff points (22) of .0.85 for women and
.0.90 for men (Supplemental Table 4). There was a 22% in-
creased risk of mortality (HR: 1.22; 95% CI: 1.09, 1.37) for
overweight participants with a higher WHR and a 42% increased
risk (HR: 1.42; 95% CI: 1.26, 1.61) for class I obese participants
with a higher WHR relative to normal-weight participants with a
lower WHR. We also conducted an analysis using a higher
threshold for men with a WHR.1.00, because.75% of the men
were classified as centrally obese with the WHO cutoff points.
The point estimates were higher for the overweight and class I
obese groups with a higher WHR (Supplemental Table 4). There
FIGURE 1 Joint association of BMI categories and WHR tertiles with mortality (A) and CAD (B). (A) Joint associations of BMI categories and WHR
tertiles with mortality (n = 130,473) for “healthier agers” aged 60–69 y from the UK Biobank. (B) Joint associations of BMI categories and WHR tertiles with
incident CAD. Previous cases of CAD were excluded (n = 10,115). Competing risk models (accounting for mortality) were used for CAD with SHRs reported.
Survival models and competing risk models were adjusted for age, sex, smoking history (never or former smoker), alcohol intake, and educational attainment.
Healthier agers included current nonsmokers and individuals without recent or disease-associated (e.g., from dementia, heart failure, or cancer) weight loss.
The first 2 y of follow-up were excluded. Values are presented as the number of participants within each category reported for mortality and CAD. The
reference group comprised individuals with a normal BMI and lower WHR tertile. WHR was categorized by population sex-specific tertiles as follows: lower
WHR, ,0.91 for men and ,0.79 for women; intermediate WHR, 0.91 to ,0.96 for men and 0.79 to ,0.85 for women; and higher WHR, $0.96 for men and
$0.85 for women. BMI categories (in kg/m2) were as follows: normal weight, 18.5 to ,25; overweight, 25 to ,30; and class I obesity, 30 to ,35. For BMI
groupings for BMI and WHR, see Table 1. CAD, coronary artery disease; Obese-1, class I obesity; SHR, sub-HR; WHR, waist-to-hip ratio.
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was no significant interaction (P , 0.05) between the joint as-
sociations of BMI and WHR tertiles with age group (60–64 y and
65–69 y), sex, physical activity, or smoking history (never or
former smoker) for mortality. We used a model to estimate how
much of the risk between the joint associations of mortality with
BMI and WHR tertiles is mediated by diabetes (additionally
adjusted for diabetes), and our estimates were not substantially
changed (Supplemental Table 5). Restricting the analyses to
participants who responded that their ethnic background was
white/British (n = 120,151) only marginally changed the results
for BMI and WHR for mortality (Supplemental Table 5); un-
fortunately, models for other ethnic groups were underpowered.
Restricting the analyses to weight-stable participants (n = 93,764)
did not substantially change the results (Supplemental Table 5).
DISCUSSION
There is much discussion in the literature about whether being
overweight, as defined by BMI, is a risk factor for CAD and all-
cause mortality in later life. We aimed to estimate associations
between combined BMI and central adiposity measurements with
mortality and incident CAD in a large cohort of older, healthier
agers. First, we found that models including both BMI and WHR
were substantively more informative than models accounting for
BMI only. For example, subjects with a normal BMI but higher
WHR had increased mortality (HR: 1.33; 95% CI: 1.08, 1.65)
compared with those with a lower WHR. We then showed that
overweight participants with a higher WHR experienced mark-
edly increased risks for all-cause mortality versus control par-
ticipants with a normal BMI and lower WHR. There was also an
increased risk of incident CAD with increasing WHR tertile
within the overweight category. For participants with class I
obesity (BMI: 30 to,35), mortality risks were increased and not
paradoxical overall, and increasing tertiles of WHR also in-
creased risk within moderate BMI-defined obesity.
It is clear from our data that higher central adiposity in both the
normal BMI range and the combination of overweight and central
adiposity should be considered a risk factor for clinical risk
assessment and public health purposes in healthy agers. Our
findings suggest that the reported risk paradox of being over-
weight in older persons (overweight associated with lower
mortality) may be attributable to failure to account for central
adiposity, a feature that is not captured by BMI. Controlling or
reducing adiposity to increase the chances of aging well (or
successful aging) is of particular relevance to our studied group of
healthier agers. Our findings therefore do not support the theory
that the overweight risk paradox in healthy agers is a real pro-
tective physiologic effect (9).
Our study inevitably has limitations, including the use of a
volunteer sample, albeit with a wide range of relevant risk ex-
posures (18). The UK Biobank did not aim for population rep-
resentativeness; because of the wide variation in exposures
included in the large sample at baseline, it is likely that the lon-
gitudinal risk estimates are relevant for the wider population (24,
25). Our sample was predominately white/British (92%), which
may limit the generalizability of our findings to different Caucasian
populations. We restricted our analyses to a “healthier agers”
group and our risk estimates may be inflated relative to the overall
population, owing to fewer competing risk factors (26), although
our exclusions were designed to remove confounding and reverse
causation. In addition, this group of healthier agers is the main
potential target for primary prevention of obesity in later life.
Data on recent weight loss or weight change in the previous 12
mo were based on participants’ self-reports at baseline. It would
have been preferable to exclude persons with weight loss over a
longer time period and to have an indication of the severity of
weight change, but these data were unavailable. Alley et al. (27)
reported that the rate of weight loss accelerated during the last 9 y
of life for men aged$60 y from the Baltimore Longitudinal Study
of Aging, so our exclusion of any weight loss in the previous year
should have accounted for this effect. Stokes and Preston (28) re-
ported that estimates using baseline BMI may underestimate the
association between obesity and mortality, because BMI fluctua-
tions throughout life are not captured; model performance was
improved through the use of a person’s maximum attained BMI.
Unfortunately, the UK Biobank did not collect data on weight
history throughout the life course, so the results from our available
BMI data may be underestimates of true effect sizes. Our follow-up
period of #8.3 y is comparable to other studies, but longer follow-
ups may be more informative. Relatively few participants in our
class I obese sample had a lower WHR, although many participants
in our normal BMI category had intermediate or higher WHRs.
Strengths of our analyses include the large sample of healthier
agers and the availability of anthropometric measurements at
baseline. In addition, outcomes were ascertained through data
from the national death certificate system and hospital records,
which are likely to be robust with no loss to follow-up, thus
avoiding a common bias in aging cohorts (29).
Our results are difficult to compare with previous work, owing
to differing groupings and WHR cutoff points, the inclusion of
varying older age ranges, and varied follow-up periods. Our
results on the association betweenWHR tertiles and mortality are
in contrast with the nonsignificant associations for the middle and
high tertiles reported by Batsis et al. (30) for mortality for adults
aged .60 y (n = 1569) from NHANES III. This could be at-
tributable to the relatively small sample size and wider age range
in the study by Batsis et al., which may have weakened the
associations. Our results on the joint association between WHR
and BMI categories differ from those of Reis et al. (31), who
reported that there was no increased risk of mortality for adults
with enlarged WHR tertiles across the normal, overweight, and
obese ranges for adults aged 65–100 y, again in a relatively
small sample size (n = 3748) from NHANES III. Our findings
for the combined association between CAD and WHR and BMI
categories are also difficult to compare with previous studies
because we used the recommended competing-risk model anal-
ysis approach, accounting for mortality.
Future work might include a more extensive analysis of al-
ternative measurements of distribution of adiposity, as well as
analyses in a wider age range and with longer follow-up.With the
accumulation of longer follow-up in UK Biobank, well-powered
cause-specific mortality estimates should become feasible.
Overall, much work is needed to develop and test effective in-
terventions to limit or reduce excessive adiposity in older groups
for whommajor gains in healthy aging may thereby be attainable.
In conclusion, in our large sample of 60- to 69-y-old nonsmokers
without prior weight loss (or related disease), risk estimation models
for mortality combining BMI and WHR were substantially more
informative than models with only BMImeasurements. The reported
BMI-based overweight risk paradox in later life appears to be
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attributable in part to central adiposity, which is not measured by
BMI. Healthier agers (i.e., nonsmokers without weight loss) with
higher central adiposity who are in the overweight BMI category
have substantial excess mortality and heart disease risk. We also
found no evidence of a risk paradox with moderate obesity, but we
instead saw overall increases in mortality compared with individuals
with a normal BMI and lower WHR. Higher levels of physical
activitywere an independent protective factor, butwe did not find that
these negated the effects of overweight or class I obesity. Overall, our
findings do not support acceptance of the overweight risk paradox
as a real protective physiologic effect in the studied older group.
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